Dr. Sanda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
The Emory Clinic
1365 Clifton Rd NE - Bldg B, Suite 1400
Atlanta, GA 30322Phone+1 404-778-6874- Is this information wrong?
Summary
- Dr. Martin Sanda is Professor and Chair of Urology at Emory Healthcare in Atlanta, GA and is affiliated with multiple hospitals in the area, including Emory University Hospital, Emory Saint Joseph's Hospital of Atlanta, and others. He received his medical degree from Columbia University College of Physicians & Surgeons, completed his Urology residency at Johns Hopkins, and has been in practice 25 years. He specializes in urological oncology with focus on prostate cancer, and has managed the care and treatment of over 2500 men with newly diagnosed prostate cancer.
Education & Training
Johns Hopkins UniversityResidency, Urology, 1991 - 1995
National Cancer InstituteFellowship, Tumor Immunology, 1989 - 1991
Virginia Commonwealth University Health SystemResidency, Surgery, 1987 - 1989
Columbia University Vagelos College of Physicians and SurgeonsClass of 1987
Certifications & Licensure
GA State Medical License 2013 - 2024
MA State Medical License 2003 - 2014
MI State Medical License 1995 - 2005
MD State Medical License 1989 - 1995- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Boston Magazine Castle Connolly, 2008-2012
Clinical Trials
- Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer Start of enrollment: 2002 Sep 01
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
- Observation or Radical Treatment in Patients With Prostate Cancer Start of enrollment: 2007 Dec 06
- Join now to see all
Publications & Presentations
PubMed
- Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.Jeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L Samora, Yashar S Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, H...> ;JAMA Oncology. 2024 Apr 18
- 1 citationsIntegrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.Moreno, C., Winham, C., Klein, E., Patil, D., Barwick, B., Huang, Y., Alemozaffar, M., Lawal, I., Abiodun-Ojo, O., Schuster, D., Sanda, M., Osunkoya, A.> ;Cancers. 2023 Nov 30
- Covariate-specific evaluation of continuous biomarker.Ziyi Li, Yijian Huang, Dattatraya Patil, Mark Rubin, Martin G Sanda> ;Statistics in Medicine. 2023 Mar 30
- Join now to see all
Journal Articles
- Impact of Prebiopsy Magnetic Resonance Imaging of the Prostate on Cancer Detection and Treatment PatternsMartin G Sanda, Christopher P Filson, Urologic Oncology
Press Mentions
Research Roundup: Recent Grants and Publications for Emory Faculty and StaffNovember 9th, 2021
Panel Discusses Present and Future of Molecular PET Imaging for Prostate CancerMay 16th, 2019
AUA, ASTRO, SUO Release Localized PCa GuidelineJune 5th, 2017- Join now to see all
Grant Support
- Harvard/Michigan/Cornell Prostate Cancer Biomarker Clinical Validation CenterNational Cancer Institute2010–2011
- Effectiveness Of Robotic Compared To Standard Prostatectomy For Prostate CancerNational Institute Of Biomedical Imaging And Bioengineering2009–2010
- Effectiveness Of Early Stage Prostate Cancer TreatmentNational Cancer Institute2009–2010
- Harvard/Michigan Prostate Cancer Biomarker Clinical CtrNational Cancer Institute2005–2010
- University Of Michigan O'Brien Center For Urology ResearchNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Survivor Qol/Spouse Satisfaction After Prostate TherapyNational Cancer Institute2004–2007
- Modulating Tolerance For Prostate Cancer Antigen VaccineNational Cancer Institute2003
- Survivor Qol/Spouse Satisfaction After Prostate TherapyNational Cancer Institute2002–2003
- Modulating Tolerance For Prostate Cancer Antigen VaccineNational Cancer Institute2000–2003
- Recombinant Vaccinia/Psa Vaccine In Patients With Recurrence Of Prostate CancerNational Center For Research Resources1998–2002
- Vaccinia PSA For Androgen-Modulated Post-Surgical Recurrence Of Prostate CancerNational Cancer Institute1998–2002
- Targeting PCD In Bladder CancerNational Cancer Institute1998–2002
- Prostate Cancer Gene Therapy With Recombinant VaccinesNational Cancer Institute1996–1999
Hospital Affiliations
Emory University HospitalAtlanta, Georgia
Emory Saint Joseph's HospitalAtlanta, Georgia
Grady Health SystemAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
